Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features

Area of Science:

• Immunology
• Pathology
• Rheumatology

Background:

• Immune-mediated inflammatory diseases (IMIDs) are multifactorial pathologies affecting multiple organs.
• Common pathogenic mechanisms exist, but variations in inflammatory cytokine profiles contribute to differing clinical courses.
• Current treatments like corticosteroids, immunosuppressors, and biologics show variable efficacy and tolerability.

Purpose of the Study:

• To review the key features of IMIDs.
• To discuss challenges in managing IMIDs, particularly treatment resistance and intolerance.
• To explore novel therapeutic strategies for combating detrimental immune responses in IMIDs.

Main Methods:

• Literature review of IMID pathogenesis and treatment.
• Analysis of common and distinct features of IMIDs.
• Discussion of current and emerging therapeutic modalities.

Main Results:

• IMIDs share underlying immune dysregulation but exhibit heterogeneity in inflammatory pathways.
• A significant subset of patients with IMIDs are intolerant or unresponsive to existing therapies.
• The need for combination therapies targeting multiple inflammatory networks or balancing suppression and activation is highlighted.

Conclusions:

• Understanding IMID heterogeneity is crucial for effective management.
• Novel therapeutic approaches are essential to address treatment gaps in IMIDs.
• Targeting both inflammatory signals and counter-regulatory pathways may offer improved outcomes for IMID patients.